Global Antibody Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Antibody Market
The global Antibody market size is projected to reach US$ 12390 million by 2027, from US$ 8634.3 million in 2020, at a CAGR of 5.3% during 2021-2027.
Global Antibody Scope and Segment
The global Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
IgM
IgG
IgA
Other
By the end users/application, this report covers the following segments
Therapeutic
Research
Diagnostic
Competitive Landscape:
The report provides a list of all the key players in the Antibody market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Antibody key manufacturers in this market include:
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

TABLE OF CONTENT

1 Antibody Market Overview
1.1 Antibody Product Overview
1.2 Antibody Market Segment by Type
1.2.1 IgM
1.2.2 IgG
1.2.3 IgA
1.2.4 Other
1.3 Global Antibody Market Size by Type
1.3.1 Global Antibody Market Size Overview by Type (2016-2027)
1.3.2 Global Antibody Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Antibody Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Antibody Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Antibody Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Antibody Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Antibody Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Antibody Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Antibody Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibody Sales Breakdown by Type (2016-2030)
1.4.2 Europe Antibody Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Antibody Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Antibody Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Antibody Sales Breakdown by Type (2016-2030)

2 Global Antibody Market Competition by Company
2.1 Global Top Players by Antibody Sales (2016-2030)
2.2 Global Top Players by Antibody Revenue (2016-2030)
2.3 Global Top Players Antibody Price (2016-2030)
2.4 Global Top Manufacturers Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody Market Competitive Situation and Trends
2.5.1 Antibody Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody as of 2020)
2.7 Date of Key Manufacturers Enter into Antibody Market
2.8 Key Manufacturers Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Antibody Status and Outlook by Region
3.1 Global Antibody Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Antibody Historic Market Size by Region
3.2.1 Global Antibody Sales in Volume by Region (2016-2030)
3.2.2 Global Antibody Sales in Value by Region (2016-2030)
3.2.3 Global Antibody Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Antibody Forecasted Market Size by Region
3.3.1 Global Antibody Sales in Volume by Region (2022-2027)
3.3.2 Global Antibody Sales in Value by Region (2022-2027)
3.3.3 Global Antibody Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Antibody by Application
4.1 Antibody Market Segment by Application
4.1.1 Therapeutic
4.1.2 Research
4.1.3 Diagnostic
4.2 Global Antibody Market Size by Application
4.2.1 Global Antibody Market Size Overview by Application (2016-2027)
4.2.2 Global Antibody Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Antibody Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Antibody Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Antibody Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Antibody Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Antibody Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Antibody Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Antibody Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antibody Sales Breakdown by Application (2016-2030)
4.3.2 Europe Antibody Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Antibody Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Antibody Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Antibody Sales Breakdown by Application (2016-2030)

5 North America Antibody by Country
5.1 North America Antibody Historic Market Size by Country
5.1.1 North America Antibody Sales in Volume by Country (2016-2030)
5.1.2 North America Antibody Sales in Value by Country (2016-2030)
5.2 North America Antibody Forecasted Market Size by Country
5.2.1 North America Antibody Sales in Volume by Country (2022-2027)
5.2.2 North America Antibody Sales in Value by Country (2022-2027)

6 Europe Antibody by Country
6.1 Europe Antibody Historic Market Size by Country
6.1.1 Europe Antibody Sales in Volume by Country (2016-2030)
6.1.2 Europe Antibody Sales in Value by Country (2016-2030)
6.2 Europe Antibody Forecasted Market Size by Country
6.2.1 Europe Antibody Sales in Volume by Country (2022-2027)
6.2.2 Europe Antibody Sales in Value by Country (2022-2027)

7 Asia-Pacific Antibody by Region
7.1 Asia-Pacific Antibody Historic Market Size by Region
7.1.1 Asia-Pacific Antibody Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Antibody Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific Antibody Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Antibody Sales in Value by Region (2022-2027)

8 Latin America Antibody by Country
8.1 Latin America Antibody Historic Market Size by Country
8.1.1 Latin America Antibody Sales in Volume by Country (2016-2030)
8.1.2 Latin America Antibody Sales in Value by Country (2016-2030)
8.2 Latin America Antibody Forecasted Market Size by Country
8.2.1 Latin America Antibody Sales in Volume by Country (2022-2027)
8.2.2 Latin America Antibody Sales in Value by Country (2022-2027)

9 Middle East and Africa Antibody by Country
9.1 Middle East and Africa Antibody Historic Market Size by Country
9.1.1 Middle East and Africa Antibody Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Antibody Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibody Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Antibody Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Antibody Business
10.1 Roche
10.1.1 Roche Corporation Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Antibody Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Roche Antibody Products Offered
10.1.5 Roche Recent Development
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Corporation Information
10.2.2 Johnson and Johnson Introduction and Business Overview
10.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Johnson and Johnson Antibody Products Offered
10.2.5 Johnson and Johnson Recent Development
10.3 Merck
10.3.1 Merck Corporation Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Antibody Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Merck Antibody Products Offered
10.3.5 Merck Recent Development
10.4 Novartis
10.4.1 Novartis Corporation Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Novartis Antibody Products Offered
10.4.5 Novartis Recent Development
10.5 AbbVie
10.5.1 AbbVie Corporation Information
10.5.2 AbbVie Introduction and Business Overview
10.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2016-2030)
10.5.4 AbbVie Antibody Products Offered
10.5.5 AbbVie Recent Development
10.6 Amgen
10.6.1 Amgen Corporation Information
10.6.2 Amgen Introduction and Business Overview
10.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2016-2030)
10.6.4 Amgen Antibody Products Offered
10.6.5 Amgen Recent Development
10.7 Pfizer
10.7.1 Pfizer Corporation Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2016-2030)
10.7.4 Pfizer Antibody Products Offered
10.7.5 Pfizer Recent Development
10.8 Bayer
10.8.1 Bayer Corporation Information
10.8.2 Bayer Introduction and Business Overview
10.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Bayer Antibody Products Offered
10.8.5 Bayer Recent Development
10.9 Lilly
10.9.1 Lilly Corporation Information
10.9.2 Lilly Introduction and Business Overview
10.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2016-2030)
10.9.4 Lilly Antibody Products Offered
10.9.5 Lilly Recent Development
10.10 Bristol-Myers Squibb
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Antibody Product Category, Application and Specification
10.10.3 Bristol-Myers Squibb Antibody Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 Bristol-Myers Squibb Recent Development
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Corporation Information
10.11.2 GlaxoSmithKline Introduction and Business Overview
10.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2016-2030)
10.11.4 GlaxoSmithKline Antibody Products Offered
10.11.5 GlaxoSmithKline Recent Development
10.12 Biogen
10.12.1 Biogen Corporation Information
10.12.2 Biogen Introduction and Business Overview
10.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Biogen Antibody Products Offered
10.12.5 Biogen Recent Development
10.13 AstraZeneca
10.13.1 AstraZeneca Corporation Information
10.13.2 AstraZeneca Introduction and Business Overview
10.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2016-2030)
10.13.4 AstraZeneca Antibody Products Offered
10.13.5 AstraZeneca Recent Development
10.14 Sanofi
10.14.1 Sanofi Corporation Information
10.14.2 Sanofi Introduction and Business Overview
10.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2016-2030)
10.14.4 Sanofi Antibody Products Offered
10.14.5 Sanofi Recent Development
10.15 Alexion Pharmaceuticals
10.15.1 Alexion Pharmaceuticals Corporation Information
10.15.2 Alexion Pharmaceuticals Introduction and Business Overview
10.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2016-2030)
10.15.4 Alexion Pharmaceuticals Antibody Products Offered
10.15.5 Alexion Pharmaceuticals Recent Development
10.16 Seattle Genetics
10.16.1 Seattle Genetics Corporation Information
10.16.2 Seattle Genetics Introduction and Business Overview
10.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2016-2030)
10.16.4 Seattle Genetics Antibody Products Offered
10.16.5 Seattle Genetics Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody Industrial Chain Analysis
11.4 Antibody Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibody Distributors
12.3 Antibody Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample